United States Electrophysiology Devices Market Outlook to 2033 - Electrophysiology Lab Systems, Electrophysiology Diagnostic Catheters and Electrophysiology Ablation Catheters
Summary
GlobalData’s “United States Electrophysiology Devices Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Electrophysiology Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Electrophysiology Lab Systems, Electrophysiology Diagnostic Catheters and Electrophysiology Ablation Catheters
The United States Electrophysiology Devices Market report provides key information and data on -
- Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
- 2023 company share and distribution share data for Electrophysiology Devices Market.
- Global corporate-level profiles of key companies operating within the United States Electrophysiology Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
United States Electrophysiology Devices is segmented as follows -
- Electrophysiology Lab Systems
- Electrophysiology Diagnostic Catheters
- Electrophysiology Ablation Catheters
The United States Electrophysiology Devices Market report helps you to develop -
- Business strategies by identifying the key market segments poised for strong growth in the future.
- Market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
- 1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
- 2 Introduction
- 2.1 What Is This Report About?
- 2.2 Electrophysiology Devices Market Segmentation
- 2.3 Definitions of Markets Covered in the Report
- 3 Electrophysiology Devices Market, United States
- 3.1 Electrophysiology Devices Market, United States, Revenue ($m), 2018-2033
- 3.1.1 Electrophysiology Ablation Catheters Market, United States, Revenue ($m), by Segment, 2018-2033
- 3.1.2 Electrophysiology Diagnostic Catheters Market, United States, Revenue ($m), by Segment, 2018-2033
- 3.1.3 Electrophysiology Lab Systems Market, United States, Revenue ($m), by Segment, 2018-2033
- 3.2 Electrophysiology Devices Market, United States, Volume (Units), 2018-2033
- 3.2.1 Electrophysiology Ablation Catheters Market, United States, Volume (Units), by Segment, 2018-2033
- 3.2.2 Electrophysiology Diagnostic Catheters Market, United States, Volume (Units), by Segment, 2018-2033
- 3.2.3 Electrophysiology Lab Systems Market, United States, Volume (Units), by Segment, 2018-2033
- 3.3 Electrophysiology Devices Market, United States, Average Price ($), 2018-2033
- 3.4 Electrophysiology Devices Market, United States, Distribution Share by Revenue ($m), 2023
- 3.5 Electrophysiology Devices Market, United States, Company Share by Revenue ($m), 2023
- 4 Overview of Key Companies in United States, Electrophysiology Devices Market
- 4.1 Biosense Webster Inc
- 4.1.1 Company Overview
- 4.2 Abbott Laboratories
- 4.2.1 Company Overview
- 4.3 Medtronic Plc
- 4.3.1 Company Overview
- 4.4 Boston Scientific Corp
- 4.4.1 Company Overview
- 4.5 GE HealthCare Technologies Inc
- 4.5.1 Company Overview
- 5 Electrophysiology Devices Market Pipeline Products
- 6 Financial Deals Landscape
- 6.1 Debt Offerings
- 6.1.1 Merit Medical Raises USD650 Million in Private Placement of 3% Convertible Senior Notes Due 2029
- 6.2 Equity Offerings
- 6.2.1 BioSig Technologies Raises USD3 Million in Private Placement of Shares
- 6.2.2 GE HealthCare Technologies Upsizes and Prices Upsized Secondary Offering of 14 Million Common Shares
- 7 Recent Developments
- 7.1 Corporate Communications
- 7.1.1 Mar 19, 2024: Autonomix Appoints Jennifer Cook as Chief Business Officer
- 7.1.2 Feb 16, 2024: Jim Robo, Former Chairman and CEO of NextEra Energy, to Join Mayo Clinic Board of Trustees
- 7.1.3 Dec 18, 2023: Merit Medical Announces Process for Chief Executive Officer Succession Planning
- 7.1.4 Nov 16, 2023: Autonomix Medical Announces Appointment of Christopher C. Capelli, M.D. to Board of Directors
- 7.1.5 Oct 04, 2023: Stereotaxis Robotic Technology to be Featured during 7th Annual Meeting of the Society for Cardiac Robotic Navigation
- 7.1.6 Aug 11, 2023: Kristin Peck, CEO of Zoetis, to join Mayo Clinic Board of Trustees
- 7.2 Financial Announcements
- 7.2.1 Jun 18, 2024: Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024
- 7.2.2 May 13, 2024: Stereotaxis Reports 2024 First Quarter Financial Results
- 7.2.3 May 07, 2024: Harvard Bioscience Announces First Quarter 2024 Financial Results
- 7.2.4 Feb 28, 2024: Merit Medical Introduces 'Continued Growth Initiatives' Program and Financial Targets for Three-Year Period Ending December 31, 2026
- 7.2.5 Feb 27, 2024: Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call For March 7, 2024 at 8:00 Am ET
- 7.2.6 Feb 15, 2024: Integer Holdings Reports Results for Fourth Quarter and Full Year 2023
- 7.2.7 Feb 14, 2024: Autonomix Medical, Reports Third Quarter FY2024 Financial Results and Reiterates Upcoming Key Milestones
- 7.2.8 Feb 06, 2024: INSERTING and REPLACING GE HealthCare Reports Fourth Quarter and Full Year 2023 Financial Results
- 7.2.9 Jan 18, 2024: GE HealthCare to Announce Fourth Quarter and Full Year 2023 Results on February 6, 2024
- 7.2.10 Jan 10, 2024: Integer Holdings Announces Preliminary Unaudited Sales Results and Acquisition of Pulse Technologies
- 7.2.11 Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
- 7.2.12 Oct 31, 2023: GE HealthCare Reports Third Quarter 2023 Financial Results
- 7.2.13 Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023
- 7.2.14 Oct 26, 2023: Integer Holdings Reports Third Quarter 2023 Results
- 7.2.15 Oct 24, 2023: Ankyra Therapeutics Receives FDA IND and Health Canada CTA Approval to Advance First-In-Class Anchored Immunotherapy Agent, ANK-101 in Solid Tumors
- 7.2.16 Oct 18, 2023: Yuyu Pharma to Attend ‘CPHI Worldwide 2023'
- 7.2.17 Sep 28, 2023: Coave Therapeutics to Present at Upcoming Conferences
- 7.2.18 Sep 28, 2023: Integer Schedules Third Quarter 2023 Earnings Release and Conference Call for October 26, 2023
- 7.3 Government and Public Interest
- 7.3.1 Mar 20, 2024: Autonomixto Present at the Benzinga Virtual Healthcare Summit 2024
- 7.3.2 Feb 14, 2024: GE HealthCare Management to Present at Upcoming Investor Conferences
- 7.3.3 Feb 09, 2024: Autonomix Medical to Present at Integrous Big Hearts, Big Ideas Virtual Investor Conference
- 7.3.4 Dec 14, 2023: Autonomix Medical to Participate in the Virtual Investor Fireside Chat
- 7.3.5 Oct 23, 2023: Sumitomo Pharma Announces Authorization in Canada of ORGOVYX for the Treatment of Men with Advanced Prostate Cancer
- 7.4 Legal And Regulatory
- 7.4.1 Oct 19, 2023: 60 Degrees Pharma to Present Safety, Efficacy Data of 8-Aminoquinolines for Malaria and Babesiosis Treatment at ILADS Annual Meeting in Boston
- 7.5 Other Significant Developments
- 7.5.1 May 24, 2024: iHealthScreen Developed and Validated Risk Prediction Models for Cardiovascular Diseases Using Individual’s Retinal Color Images and Health Data
- 7.5.2 Jan 11, 2024: Autonomix Medical, Inc. Completes Formation of Engineering Development Team and Provides Project Update
- 7.5.3 Jan 04, 2024: Autonomix Medical, Inc. Provides Business Overview and Highlights Upcoming Milestones
- 7.6 Product News
- 7.6.1 Dec 15, 2023: Strukmyer Receives 510(K) Clearance For Comatryx Dressing - OTC
- 8 Appendix
- 8.1 Research Methodology
- 8.1.1 Coverage
- 8.1.2 Secondary Research
- 8.1.3 Primary Research
- 8.1.4 Market Modeling and Forecasting
- 8.1.5 Company Share Analysis
- 8.1.6 Distribution Share Analysis
- 8.1.7 Benchmarking
- 8.2 GlobalData Consulting
- 8.3 Contact Us
- 8.4 Disclaimer
- List of Tables
- Table 1: Electrophysiology Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
- Table 2: Electrophysiology Ablation Catheters Market, United States, Revenue ($m), USD Constant, 2018-2033
- Table 3: Electrophysiology Diagnostic Catheters Market, United States, Revenue ($m), USD Constant, 2018-2033
- Table 4: Electrophysiology Lab Systems Market, United States, Revenue ($m), USD Constant, 2018-2033
- Table 5: Electrophysiology Devices Market, United States, Volume (Units), 2018-2033
- Table 6: Electrophysiology Ablation Catheters Market, United States, Volume (Units), 2018-2033
- Table 7: Electrophysiology Diagnostic Catheters Market, United States, Volume (Units), 2018-2033
- Table 8: Electrophysiology Lab Systems Market, United States, Volume (Units), 2018-2033
- Table 9: Electrophysiology Devices Market, United States, Average Price ($), 2018-2033
- Table 10: Electrophysiology Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023
- Table 11: Electrophysiology Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2023
- Table 12: Electrophysiology Devices Market Pipeline Products
- Table 13: Merit Medical Raises USD650 Million in Private Placement of 3% Convertible Senior Notes Due 2029
- Table 14: BioSig Technologies Raises USD3 Million in Private Placement of Shares
- Table 15: GE HealthCare Technologies Upsizes and Prices Upsized Secondary Offering of 14 Million Common Shares
- Table 16: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country
- List of Figures
- Figure 1: Electrophysiology Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
- Figure 2: Electrophysiology Ablation Catheters Market, United States, Revenue ($m), USD Constant, 2018-2033
- Figure 3: Electrophysiology Diagnostic Catheters Market, United States, Revenue ($m), USD Constant, 2018-2033
- Figure 4: Electrophysiology Lab Systems Market, United States, Revenue ($m), USD Constant, 2018-2033
- Figure 5: Electrophysiology Devices Market, United States, Volume (Units), 2018-2033
- Figure 6: Electrophysiology Ablation Catheters Market, United States, Volume (Units), 2018-2033
- Figure 7: Electrophysiology Diagnostic Catheters Market, United States, Volume (Units), 2018-2033
- Figure 8: Electrophysiology Lab Systems Market, United States, Volume (Units), 2018-2033
- Figure 9: Electrophysiology Devices Market, United States, Company Share (%) 2023
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook